You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Human chimeric antigen receptor macrophages for cancer immunotherapy
|
|---|---|
| Published in |
Nature Biotechnology, March 2020
|
| DOI | 10.1038/s41587-020-0462-y |
| Pubmed ID | |
| Authors |
Michael Klichinsky, Marco Ruella, Olga Shestova, Xueqing Maggie Lu, Andrew Best, Martha Zeeman, Maggie Schmierer, Konrad Gabrusiewicz, Nicholas R. Anderson, Nicholas E. Petty, Katherine D. Cummins, Feng Shen, Xinhe Shan, Kimberly Veliz, Kristin Blouch, Yumi Yashiro-Ohtani, Saad S. Kenderian, Miriam Y. Kim, Roddy S. O’Connor, Stephen R. Wallace, Miroslaw S. Kozlowski, Dylan M. Marchione, Maksim Shestov, Benjamin A. Garcia, Carl H. June, Saar Gill |
X Demographics
The data shown below were collected from the profiles of 384 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 131 | 34% |
| United Kingdom | 17 | 4% |
| Japan | 10 | 3% |
| France | 9 | 2% |
| Canada | 8 | 2% |
| Australia | 8 | 2% |
| Germany | 8 | 2% |
| Mexico | 3 | <1% |
| Switzerland | 3 | <1% |
| Other | 47 | 12% |
| Unknown | 140 | 36% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 230 | 60% |
| Scientists | 126 | 33% |
| Practitioners (doctors, other healthcare professionals) | 17 | 4% |
| Science communicators (journalists, bloggers, editors) | 11 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 1,223 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1223 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 248 | 20% |
| Student > Ph. D. Student | 208 | 17% |
| Student > Master | 110 | 9% |
| Student > Bachelor | 95 | 8% |
| Student > Doctoral Student | 55 | 4% |
| Other | 143 | 12% |
| Unknown | 364 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 293 | 24% |
| Immunology and Microbiology | 161 | 13% |
| Agricultural and Biological Sciences | 86 | 7% |
| Medicine and Dentistry | 79 | 6% |
| Engineering | 48 | 4% |
| Other | 156 | 13% |
| Unknown | 400 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 460. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 April 2024.
All research outputs
#60,688
of 25,775,807 outputs
Outputs from Nature Biotechnology
#115
of 8,622 outputs
Outputs of similar age
#2,121
of 393,788 outputs
Outputs of similar age from Nature Biotechnology
#10
of 97 outputs
Altmetric has tracked 25,775,807 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,622 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 44.5. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 393,788 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 97 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.